Benztropine mesylate 2 mg Oral Tablet
RxNorm 885209
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 885209 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: benztropine mesylate 2 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Benztropine mesylate 2 mg Oral Tablet
(Atom ID: 3033217)
SYPrescribable
Synonym (SY):
Benzatropine mesilate 2 mg oral tablet
(Atom ID: 11824430)
PSNPrescribable
Prescribable Name (PSN):
Benztropine mesylate 2 mg Oral Tablet
(Atom ID: 6365360)
PTPrescribable
Designated preferred name (PT):
Benztropine mesylate 2 mg oral tablet
(Atom ID: 9249066)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely benzatropine mesilate 2 mg/1 each conventional release oral tablet (clinical drug)
(Atom ID: 11826510)
Patient Education
Benztropine
Benztropine is used along with other medications to treat the symptoms of Parkinson's disease (PD; a disorder of the nervous system that causes difficulties with movement, muscle control, and balance) and tremors caused by other medical problems or medications. Benztropine is in a class of medications called anticholinergics. It works by blocking a certain natural substance (acetylcholine) to help to decrease symptoms in people with Parkinson's disease.
[Learn More]
* Please review the disclaimer below.